by Peace Chukwu | Jun 18, 2025
For decades, exosomes were seen as the cell’s garbage collection system. The understanding of their function was limited to cellular waste disposal, removing unwanted substances from the cell. Now, researchers are making the shift from using whole stem cells to...
by Anis Fahandej-Sadi | Jun 5, 2025
Cancer treatment has advanced dramatically, but a central challenge remains: the newest tools in our arsenal are shockingly expensive. CAR T-cell therapies exemplify this—they’re amazing at fighting blood cancers, but a single treatment costs upwards of...
by Kevin Robb | May 22, 2025
For the first time, mesenchymal stromal cells (MSCs) can be used in routine clinical practice under the nod of regulatory approval in the United States. The MSC product known as Ryoncil was made available to patients in March 2025 following a historic decision from...
by Lyla El-Fayomi | May 16, 2025
In this edition of RMNU🔬, we’re keeping up with multiple research advances in the vision repair field. Also, Vertex Pharmaceuticals is dropping a big therapeutic from their portfolio, and Longeveron has a new publication. Of course, yet another round of updates on...
by CCRM Australia | Apr 21, 2025
This post was written by Tavin Fonseka (see LinkedIn page) with supervision by Dr. Chih Wei Teng. Imagine a world where injuries that once ended careers became nothing more than mere setbacks. Athletes will heal faster, stronger, and with a greater resiliency...
by Lyla El-Fayomi | Apr 16, 2025
A brief recap You might recall Johanne Provost’s story, which I covered in the September edition of RMNU🔬. New details have since emerged regarding the specifics of her disease: Ms. Provost had been suffering from a rare autoimmune disease – lichen planus – that...
Comments